Management of type 2 diabetes: summary of updated NICE guidance

doi:10.1136/bmj.39560.442095.AD

BMJ 2008;336:1306-1308 (7 June), doi:10.1136/bmj.39560.442095.AD

Practice

Guidelines

Management of type 2 diabetes: summary of updated NICE guidance

Philip Home, professor of diabetes medicine ¹, Jonathan Mant, professor of primary care stroke research², Jose Diaz, health services research fellow in guideline development³, Claire Turner, senior project manager in guideline development for the development group ³, on behalf of the Guideline Development Group

¹ Newcastle University, The Medical School, Newcastle upon Tyne , ² Department of Primary Care and General Practice, University of Birmingham, Birmingham, ³ National Collaborating Centre for Chronic Conditions, Royal College of Physicians, London

Correspondence to: Professor P Home, SCMS-Diabetes, The Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH philip.home@ncl.ac.uk

The first 150 words of the full text of this article appear below.

Why read this summary?

The prevalence of type 2 diabetes is rising rapidly.¹ More than240 million people worldwide are estimated to have diabetes,and this number is likely to reach over 360 million by 2030.¹² The impact on health occurs primarily through cardiovasculardisease, but younger age of onset and advances in the preventionof cardiovascular disease are increasingly exposing people tothe risks of microvascular damage, such as kidney and eye disease.¹

The management of diabetes is complex and needs to address theprevention of cardiovascular disease and microvascular diseaseand the detection and management of early vascular complications.³In recent years new evidence has accumulated on lifestyle intervention,self management through education, and self monitoring, andmany new treatments have been introduced for various aspectsof management. This article summarises the recommendations froman updated guideline by the National Institute for Health andClinical Excellence (NICE) on the management of type . . . [Full text of this article]

Recommendations

Patient centred care
Blood pressure lowering treatment
Glucose lowering treatment
Blood lipid control and other cardiovascular risk management approaches
Kidney, eye, nerve, and foot problems

Overcoming barriers

Further information on the guidance
Background
Methods
Future research

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati What's this?

Relevant Articles

Commentary: controversies in NICE guidance on management of type 2 diabetes: Stephen Atkin and Christopher Walton
BMJ 2008 336: 1308-1309. [Extract] [Full Text] [PDF]

Prevention and early detection of vascular complications of diabetes: Sally M Marshall and Allan Flyvbjerg
BMJ 2006 333: 475-480. [Extract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

A missed opportunity to correct the dietary advice given to people with diabetes: Katharine Morrison
bmj.com, 10 Jun 2008 [Full text]
A Missed Opportunity: Victoria H Corkhill, et al.
bmj.com, 11 Jun 2008 [Full text]
Blood lipid control: Charles van Heyningen, et al.
bmj.com, 12 Jun 2008 [Full text]
Widespread use of fibrates in type 2 diabetes is not supported by the evidence: David J Preiss, et al.
bmj.com, 20 Jun 2008 [Full text]
Re: Blood lipid control: Philip Home, et al.
bmj.com, 27 Sep 2008 [Full text]